
Dissociative · arylcyclohexylamine
Ketamine
aka K · Ket · Kit Kat · Special K · Vitamin K
Last verified
Ketamine is an NMDA receptor antagonist originally developed as a dissociative anesthetic. At sub-anesthetic doses it produces euphoria, body dissociation, sensory distortion and (at higher doses) the so-called "k-hole" — a deep dissociated state that can feel like leaving one's body or being in another reality entirely. It is also being studied and used clinically as a rapid-onset antidepressant.
Chronic, heavy use of ketamine is associated with serious, sometimes irreversible bladder damage (ketamine-induced cystitis) and cognitive impairment. The dose-response relationship is steep; what feels like 1.5× a normal dose can land in a k-hole; and tolerance builds within days, encouraging escalating use.
Harm reduction
- Weigh your doses. Eyeballing ketamine is unreliable; a small kitchen scale (0.01 g precision) is the right tool. Pre-measured bumps in a small container help avoid creeping doses.
- Wait 60 minutes between bumps. The temptation to chase the come-up is the single largest driver of unintended k-holes.
- Never combine with depressants. GHB/GBL, opioids, alcohol and benzodiazepines all cause respiratory depression. Ketamine combined with any of them sharply increases the risk of unconsciousness, vomiting and aspiration.
- K-hole posture matters. If you go deeper than intended, you may be unable to move. Lie on your side in a safe place. Never k-hole alone in a chair or near hard edges.
- Watch your bladder. If urination becomes painful, frequent, urgent or bloody, stop using completely. Bladder symptoms can persist or progress after stopping; see a urologist early.
- Frequency matters more than dose. Multiple sessions per week (or daily use) is where the worst harms cluster. Most users tolerate occasional ketamine well for years; daily users routinely develop serious problems within months.
Dosage.
- Threshold
- 10 mg
- Light
- 20–50 mg
- Common
- 50–100 mg
- Strong
- 100–150 mg
- Heavy
- 150 mg
- Threshold
- 40 mg
- Light
- 75–150 mg
- Common
- 150–300 mg
- Strong
- 300–450 mg
- Heavy
- 450 mg
- Threshold
- 10 mg
- Light
- 15–40 mg
- Common
- 40–75 mg
- Strong
- 75–125 mg
- Heavy
- 125 mg
| Route | Threshold | Light | Common | Strong | Heavy |
|---|---|---|---|---|---|
| Insufflated | 10 mg | 20–50 mg | 50–100 mg | 100–150 mg | 150 mg |
| Oral | 40 mg | 75–150 mg | 150–300 mg | 300–450 mg | 450 mg |
| Intramuscular | 10 mg | 15–40 mg | 40–75 mg | 75–125 mg | 125 mg |
Start at the bottom. Body chemistry, tolerance, and combinations all matter.
Duration.
Insufflated
total ~ 340 min- Onset
- 5–10 min
- Peak
- 30–45 min
- Offset
- 30–45 min
- After
- 60–240 min
Oral
total ~ 600 min- Onset
- 10–30 min
- Peak
- 45–90 min
- Offset
- 60–120 min
- After
- 2–6h
Intramuscular
total ~ 245 min- Onset
- 1–5 min
- Peak
- 20–30 min
- Offset
- 20–30 min
- After
- 60–180 min
Effects.
Positive
- Euphoria
- Dissociation from body
- Music and sound enhancement
- Reduction of physical pain
- Anti-depressant effects (low doses, infrequent use)
Neutral
- Time distortion
- Visual changes (motion blur, depth flattening)
- Nystagmus (involuntary eye movement)
- Slurred speech
Negative
- Severe ataxia (loss of motor coordination) at high doses
- Nausea, especially when combined with food or alcohol
- K-hole (intense ego dissolution / out-of-body experience; sought by some, terrifying for others)
- Bladder damage with chronic frequent use (a serious risk)
- Memory impairment short-term, and possibly long-term with heavy use
Interactions.
Heads up
Combination may cause serious harm. Avoid.
- tramadol
- ghb
- opioids
- alcohol
Substantial risk. Combination not recommended.
- dxm
- benzodiazepines
- gbl
Mild interaction. Use with reduced doses.
- stimulants
- mdma
- cannabis
- psychedelics
Testing.
- ReagentMorrisExpected reactionYellow to orange (after 30 seconds)
- ReagentMeckeExpected reactionNo reaction (negative expected)
- ReagentMandelinExpected reactionOrange-brown
- ReagentSimonExpected reactionNo reaction
| Reagent | Expected reaction |
|---|---|
| Morris | Yellow to orange (after 30 seconds) |
| Mecke | No reaction (negative expected) |
| Mandelin | Orange-brown |
| Simon | No reaction |
Cross-check with a secondary reagent. Tests tell you what something isn't, not always what it is.
Legal status.
- DEGermanyPrescription only
- ATAustriaPrescription only
- CHSwitzerlandIllegal
- NLNetherlandsSchedule I
- BEBelgiumSchedule I
- LULuxembourgPrescription only
- FRFranceIllegal
- ESSpainIllegal
- PTPortugalPrescription only
- ITItalyPrescription only
- PLPolandPrescription only
- CZCzechiaPrescription only
- SESwedenPrescription only
- DKDenmarkPrescription only
- NONorwayPrescription only
- FIFinlandPrescription only
- IEIrelandClass B
- UKUnited KingdomClass B
- USUnited StatesSchedule III
- CACanadaSchedule I
- AUAustraliaSchedule 8
- TRTurkeyPrescription only
| Country | Status |
|---|---|
| DEGermany | Prescription only |
| ATAustria | Prescription only |
| CHSwitzerland | Illegal |
| NLNetherlands | Schedule I |
| BEBelgium | Schedule I |
| LULuxembourg | Prescription only |
| FRFrance | Illegal |
| ESSpain | Illegal |
| PTPortugal | Prescription only |
| ITItaly | Prescription only |
| PLPoland | Prescription only |
| CZCzechia | Prescription only |
| SESweden | Prescription only |
| DKDenmark | Prescription only |
| NONorway | Prescription only |
| FIFinland | Prescription only |
| IEIreland | Class B |
| UKUnited Kingdom | Class B |
| USUnited States | Schedule III |
| CACanada | Schedule I |
| AUAustralia | Schedule 8 |
| TRTurkey | Prescription only |
Information, not legal advice. Status varies by region and changes over time.